Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging.

MLA

D’Hollander, Antoine, et al. “Development of Nanostars as a Biocompatible Tumor Contrast Agent: Toward in Vivo SERS Imaging.” International Journal of Nanomedicine, vol. 11, Aug. 2016, pp. 3703–14. EBSCOhost, https://doi.org/10.2147/IJN.S91340.

APA

D’Hollander, A., Mathieu, E., Jans, H., Vande Velde, G., Stakenborg, T., Van Dorpe, P., Himmelreich, U., & Lagae, L. (2016). Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging. International Journal of Nanomedicine, 11, 3703–3714. https://doi.org/10.2147/IJN.S91340

Chicago

D’Hollander, Antoine, Evelien Mathieu, Hilde Jans, Greetje Vande Velde, Tim Stakenborg, Pol Van Dorpe, Uwe Himmelreich, and Liesbet Lagae. 2016. “Development of Nanostars as a Biocompatible Tumor Contrast Agent: Toward in Vivo SERS Imaging.” International Journal of Nanomedicine 11 (August): 3703–14. doi:10.2147/IJN.S91340.